XML 82 R67.htm IDEA: XBRL DOCUMENT v3.22.1
SUBSEQUENT EVENT (Details) - Subsequent Event - Dragonfly Therapeutics Collaboration Agreement - Dragonfly Therapeutics, Inc.
$ in Millions
1 Months Ended
Apr. 30, 2022
USD ($)
Subsequent Event [Line Items]  
Payments to acquire in process research and development $ 300
Royalty percentage (up to) 20.00%